The Centers for Medicare & Medicaid Services (CMS) finalized policies that increase access to artificial hearts and ventricular assist devices (VADs). In August, CMS proposed the coverage policy updates meant to increase access to VADs and artificial hearts, which represented potentially good news for major VAD makers Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) and for people with heart failure who […]
Vascular
Study: Medtronic touts cryoablation results are better than medication
Medtronic (NYSE:MDT) today announced successful results from its STOP AF First clinical trial for cryoablation treatment. Published in the New England Journal of Medicine, results showed that cryoablation with the Arctic Front Advance Cardiac Cryoballoon and Freezor MAX cardiac cryoablation catheter is superior as a first-line treatment for preventing atrial arrhythmia recurrence compared to the use […]
Acutus appoints chief translational science officer
Acutus Medical (NSDQ:AFIB) announced that it appointed Dr. Steven Mickelsen as its chief translational science officer. Carlsbad, Calif.-base Acutus, which develops cardiac mapping technology, said in a news release that Mickelsen is set to guide the company’s vision to deliver the “most advanced electrophysiology therapeutic solutions on the market for physicians and their patients.” Mickelsen […]
Surmodics rises on mixed bag Q4
Surmodics (NSDQ:SRDX) shares ticked up to end the day on fourth-quarter results that beat the consensus earnings forecast. The Eden Prairie, Minn.-based in vitro technology developer posted losses of -$2.9 million, or -22¢ per share, on sales of $22.5 million for the three months ended Sept. 30, 2020, for a bottom-line slide into the red on […]
Masimo to acquire Lidco for $40.1M
Masimo (NSDQ:MASI) today confirmed that it is set to acquire advanced hemodynamic monitoring device maker Lidco for approximately $40.1 million. Both companies’ boards confirmed in an announcement that they agreed on the terms of a recommended cash offer to be made by Masimo for the entire issued and to be issued share capital of Lidco, totaling […]
Merit Medical beats The Street in Q3, updates guidance
Merit Medical (NSDQ:MMSI) shares ticked up today on third-quarter results that topped the consensus forecast. The South Jordan, Utah-based company posted losses of -$3 million, or -5¢ per share, on sales of $243.98 million for the three months ended Sept. 30, 2020, for an 11.4% bottom-line gain on sales growth of 0.3%. Adjusted to exclude one-time […]
Medtronic wins FDA approval for self-expanding venous stent
Medtronic (NYSE:MDT) announced that it received FDA approval for its Abre venous self-expanding stent system. Fridley, Minn.-based Medtronic’s Abre stent system received an indication for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction, which is also known as deep venous obstruction, according to a news release. Abre is intended for permanent […]
DTW: Philips’ Imaged Guided leader Landon shares global giant’s plans for minimally invasive devices
In this week’s DeviceTalks Weekly podcast, we visit with Chris Landon, senior vice president and business leader of image guided therapy devices at Philips about that company’s plans to build a medtech powerhouse. In this conversation we’ll learn: Why Landon left Medtronic Where Philips fits into medtech’s future How Philips hopes to expand Will Philips […]
FDA clears Aidoc triage of incidental pulmonary embolism
Aidoc announced today that it received FDA clearance for the commercial use of its triaging algorithms for pulmonary embolism. New York-based Aidoc’s triaging and notification algorithms designed to flag and communicate incidental pulmonary embolism offers increased efficiency in prioritizing incidental critical conditions through artificial intelligence (AI), according to a news release. The technology offers an […]
Philips touts post-stent imaging study results
Royal Philips (NYSE:PHG) announced today that one-year results of its Define PCI study that reported improved outcomes and less recurrent angina. The Define PCI study assessed the level of residual ischemia found in patients following a percutaneous coronary intervention (PCI) using a blinded instant wave-free ratio (iFR) pullback measurement, which is a guidance technology unique to […]
SpectraWave names new CEO
Coronary artery disease (CAD) treatment startup SpectraWave announced today that it has appointed Eman Namati as its new CEO. Bedford, Mass.-based SpectraWave is developing a medical imaging platform that uses photonics to improve CAD outcomes. Namati joins with more than a decade of experience leading the development and launch of highly technical medical imaging products, […]
